PASW (Ping An Biomedical Co., Ltd. Ordinary Shares) Stock Analysis - News

Ping An Biomedical Co., Ltd. Ordinary Shares (PASW) is a publicly traded the market company. As of May 21, 2026, PASW trades at $0.15 with a market cap of $18.99M and a P/E ratio of 0.00. PASW moved -3.78% today. Year to date, PASW is -71.60%; over the trailing twelve months it is flat. Its 52-week range spans $0.12 to $1.22. Rallies surfaces PASW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in PASW news today?

Ping An Biomedical Approves $312,500 Capital Increase and 100M High-Vote Shares: Ping An Biomedical boosted authorized capital from US$50,000 to US$312,500 by adding 4.2 billion shares and introduced 100 million Class B shares carrying 100 votes each. The board secured approval to exchange 12.25 million Class A shares for Class B shares with INSPIRETECH and consolidate shares at up to a 1,000-to-1 ratio.

PASW Key Metrics

Key financial metrics for PASW
MetricValue
Price$0.15
Market Cap$18.99M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$1.22
52-Week Low$0.12
Volume100
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PASW News

PASW Analyst Consensus

PASW analyst coverage data. Average price target: $0.00.

Common questions about PASW

What changed in PASW news today?
Ping An Biomedical Approves $312,500 Capital Increase and 100M High-Vote Shares: Ping An Biomedical boosted authorized capital from US$50,000 to US$312,500 by adding 4.2 billion shares and introduced 100 million Class B shares carrying 100 votes each. The board secured approval to exchange 12.25 million Class A shares for Class B shares with INSPIRETECH and consolidate shares at up to a 1,000-to-1 ratio.
Does Rallies summarize PASW news?
Yes. Rallies summarizes PASW news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PASW research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PASW. It does not provide personalized investment advice.
PASW

PASW